cambridge's bluebird bio licenses delivery tech to novartis, gsk..
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..